Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who do not respond well to psychostimulant monotherapy may benefit from adding guanfacine extended-release (Intuniv, Shire), a post hoc analysis of a randomized controlled trial ...
from Meta Search Alerts http://ift.tt/1nN6gEM
via IFTTT
from Meta Search Alerts http://ift.tt/1nN6gEM
via IFTTT
No comments:
Post a Comment